Assessment of patients readmitted with venous thromboembolism within 30 days from index admission for high risk factor Abdullah O. Alshehry, PharmD, MBA; Allison Wilson, PharmD, BCPS; Michelle Murillo, PharmD; Wilda Chung On, PharmD, MBA; Kim Ngo, PharmD; Erica Martin, PharmD; BCPS, Nghi (Andy) Bui, PharmD, BCPS PURPOSE
RESULTS
To compare patients readmitted with VTE and without VTE within 30 days from index admission to identify risk factors that predisposed them to readmissions with VTE, modelling off the CRAM criteria.
Data for 100 patients in each group were evaluated. Some VTE risk factors were numerically higher in the VTE group compared to the control group, such as obesity (72 vs 66), sepsis (26 vs 3), pneumonia (25 vs. 6), malignancy (24 vs. 10), stroke (7 vs. 0) or a history of hip, pelvis, or leg fracture (17 vs. 3). The median Caprini score was 8 points (IQR = 5 -11) in the VTE groups and 6 points (IQR = 5 -7) in the control group. A total of 34 patients in the VTE group received appropriate VTE prophylaxis compared to 57 patients in the control group.
METHODS
In this retrospective chart review, patients readmitted within 30 days to the Houston Methodist Hospital System, Houston, Texas from 2016 to 2020 with VTE as a principal diagnosis were compared to patients readmitted within 30 days without VTE. The objective of this study was to describe the differences in baseline characteristics, comorbidities, and contributing risk factors for VTE, based on risk factors assessed in the Caprini Risk Assessment Model (CRAM).
CONCLUSION
Malignancy and diseases with inflammatory burden were associated with increased risk of readmission with VTE within 30 days. Caprini score may provide a better objective predictor of VTE risk within 30 days from hospitalization.
PGY1 PHARMACY RESIDENCY - INTERNATIONAL GRADUATES
Abdullah Alshehry, PharmD Abdullah earned his BS in Pharmacy from King Saud University in Riyadh, Saudi Arabia in 2010 and PharmD and MBA from Long Island University, New York, NY in 2010. Following completion of his PGY1, Abdullah will practice as clinical pharmacist at King Fahad Medical City,Riyadh, KSA. Primary project preceptor: Nghi (Andy) Bui, PharmD, BCPS Presented at 2021 Virtual Midwest Pharmacy Residents Conference
14
|
